Zynext Ventures
Overview
Zynext Ventures is the corporate venture capital arm of Zydus Lifesciences, a global pharmaceutical company. It is a new-age venture capital firm that invests in seed, early-stage, and growth-stage disruptive healthcare technologies, including novel therapeutics, gene therapy, cell therapy, and AI in drug discovery, with the potential to fill significant unmet needs.
Portfolio Companies
4
Website
zynextventures.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Promaxo | Jul 2024 | Series B Extension | Co-investor |
| neuro42 | Aug 2024 | Strategic | Lead |
| Feldan Therapeutics | Apr 2025 | Series B | Co-investor |
| Illexcor Therapeutics | Mar 2025 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Zynext Ventures based?
Zynext Ventures is headquartered in Pennington, New Jersey, United States.
When was Zynext Ventures founded?
Founding year information for Zynext Ventures is not publicly available.
How many portfolio companies does Zynext Ventures have?
Zynext Ventures has 4 portfolio companies in Caplight's dataset.
What are some companies in Zynext Ventures's portfolio?
Portfolio companies visible on Caplight include Promaxo, neuro42, Feldan Therapeutics, Illexcor Therapeutics.
What was Zynext Ventures's most recent investment shown here?
Zynext Ventures's most recent investment in this portfolio sample was in Feldan Therapeutics in 2025.
What sectors does Zynext Ventures focus on?
Zynext Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Zynext Ventures focus on?
Stage focus information for Zynext Ventures is not publicly available.